Long-term effects of recombinant human erythropoietin in patients treated with continuous peritoneal dialysis: safety aspects

Contrib Nephrol. 1991:88:169-79; discussion 180-1.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Anemia / drug therapy*
  • Erythropoietin / adverse effects*
  • Female
  • Hemoglobins / analysis
  • Humans
  • Hypertension / etiology
  • Male
  • Middle Aged
  • Peritoneal Dialysis, Continuous Ambulatory*
  • Peritonitis / etiology
  • Recombinant Proteins / adverse effects

Substances

  • Hemoglobins
  • Recombinant Proteins
  • Erythropoietin